Declaring Research Reagents in Argentina

A research reagent enters Argentina under Chapter 38 or Chapter 29 of the MERCOSUR Common Nomenclature (NCM) and clears through ARCA with a commercial invoice, transport document, safety data sheet (SDS), certificate of analysis for the batch (COA), and an end-use declaration stating the material is intended exclusively for in vitro laboratory research. That declaration is what separates the procedure from a pharmaceutical import and what determines whether ANMAT becomes involved.

What Argentine customs means by "research reagent"

There is no category in Argentine customs nomenclature called "research reagent" by that exact name. What exists is a set of NCM headings — primarily in Chapter 29 (organic chemicals) and Chapter 38 (miscellaneous chemical products and preparations) — that group laboratory substances without an authorized pharmaceutical use in the local market.

A synthetic peptide acquired as a reference material — with a certificate of analysis issued by an independent analytical laboratory and no therapeutic indication — qualifies under that framing when it is correctly declared. What distinguishes it from a medicine is not the molecule but the documentation supporting the import: the supplier must issue the paperwork that establishes the laboratory destination before the goods cross the border.

PeptoClinic supplies research reagents to Argentine destinations with that documentation prepared for each shipment, including the COA signed by the analytical laboratory, the SDS, and the technical information required for customs clearance.

The NCM code: the classification that sets the rules

Each NCM heading carries its own import duty rate and its own prior-approval requirements. For peptide laboratory reagents, the most common headings are:

Chapter 38, heading 3822: Laboratory or diagnostic reagents on any backing. This heading applies when the material is sold explicitly as an in vitro standard or reagent, without clinical indication. Many Argentine research laboratories and scientific institutions import under this heading.

Chapter 29, subheadings 2924, 2933 and 2937: Specific organic chemical compounds, including amide-function compounds, nitrogen-heterocyclic compounds, and hormone-derived compounds. Some synthetic peptides, depending on their chemical structure, fall under these subheadings rather than 3822.

The correct code is not optional. The Argentine Customs Code requires that the classification correspond to the chemical nature of the product, not the buyer's intention. A misassigned code can generate a duty discrepancy, a referral to ANMAT, or a shipment hold. This is why institutions that import these materials work with a licensed customs broker — the operator authorized to file the declaration with ARCA.

To verify the tariff heading for a specific compound, the ARCA tariff schedule is available on the Argentine government portal.

Documents ARCA requires

To release a research reagent shipment through Argentine customs, the importer must present:

Commercial invoice: issued by the foreign supplier, with a technical description of the product (IUPAC name or scientific denomination, not a generic name), lot number, quantity, unit of measure, proposed NCM code, and the transaction value in the agreed currency. A vague description such as "chemical compound" is not sufficient for clearance.

Bill of lading or airway bill: the transport document proving the shipment. Small research peptide shipments typically travel by air, so the document is generally an airway bill (AWB).

Packing list: a breakdown of the contents of each package, gross and net weight, dimensions, and packaging conditions. For materials that require cold chain, the packing list must specify the thermal packaging type used.

Safety data sheet (SDS): mandatory for any imported chemical substance. Argentine regulations recognize SDS documents in GHS format. It must identify the specific lot and compound; a generic SDS for the chemical family is not sufficient.

Certificate of analysis (COA): the document establishing the batch composition, purity measured by HPLC or another instrumental analytical method, and the data of the laboratory that performed the analysis. It is the document most relevant to demonstrating that the material matches the declaration. The quality reports on the PeptoClinic website are issued by Janoshik Analytical with HPLC analysis, a task number, and per-batch purity results.

Depending on the NCM code and the shipment value, ARCA may also require an automatic or non-automatic import license. Confirming this with the customs broker before placing the order prevents clearance delays.

The end-use declaration: the key document

The end-use declaration is a signed note from the importer — the research institution, laboratory, or responsible technical officer — specifying the destination of the material. For research reagents, the text must state that the product is for exclusive use in in vitro laboratory research, that it will not be administered to humans or animals, and that it will not be repackaged or resold as a medicinal product.

This declaration is not a standard ARCA form. The importer drafts it and attaches it to the clearance file. Three points that must appear explicitly:

• The material is acquired under the RUO category (Research Use Only)
• The destination is exclusively in vitro laboratory use
• The buyer is responsible for compliance with applicable regulations governing use and storage

Without this declaration, customs may classify the shipment as a pharmaceutical product based on molecular similarity and refer it to ANMAT, halting the clearance process.

When ANMAT becomes involved

ANMAT (the Argentine national authority for medicines, food and medical technology) intervenes when an imported substance is registered as a medicine in Argentina, or when customs interprets that the material may be intended for therapeutic use. In that case, ANMAT requires either registration of the product in the medicinal specialties registry or a specific import authorization for clinical research.

Research reagents imported with a COA, SDS, and an end-use declaration that explicitly states the in vitro laboratory destination generally do not require ANMAT involvement. The key is the combination of the correct NCM code and documentation that is consistent with that code.

For compounds that have a registered analogue as a medicine in any country, or that may be held based on the name of the chemical family, consulting a regulatory advisor before placing the first shipment is the practical way to anticipate the process. ANMAT's regulatory information on research imports is available on its official website.

The PeptoClinic catalogue states the status of each available compound. None is approved for human or veterinary use in any jurisdiction.

Who can import

Importing goods into Argentina requires registration as an authorized importer with ARCA, with an active CUIT and importer status in the Importers and Exporters Registry. Natural persons can import under certain conditions and thresholds, but most research institutions — universities, CONICET, private laboratories — file the import in the entity's name with a customs broker acting as representative before the agency.

The customs broker is the operator who knows the current nomenclature, manages prior licenses when required, and files the documentation in ARCA systems. For materials with no prior import history at the institution, the first operation may take longer while the NCM code agreed with customs is established.

For details on how PeptoClinic prepares shipment documentation to Argentine destinations, the starting point is the Argentina shipping page.

Research material: legal framework

The material PeptoClinic supplies is intended exclusively for in vitro research and laboratory use. It is not a medicine, not a dietary supplement, and not approved for administration to humans or animals.

None of the compounds in the catalogue holds approval from ANMAT, the FDA, or any other regulatory agency for clinical, diagnostic, or therapeutic use. PeptoClinic does not issue administration protocols, does not indicate doses, and does not provide guidance on use in humans. The use of RUO material outside a laboratory setting is the sole responsibility of the party carrying it out.